Oxomemazine/guaifenesin
From Infogalactic: the planetary knowledge core
Combination of | |
---|---|
Oxomemazine | H1 receptor antagonist (antihistamine) |
Guaifenesin | expectorant |
Clinical data | |
Trade names | Toplexil and others |
Routes of administration |
Oral |
Identifiers | |
ATC code | none |
Oxomemazine/guaifenesin is a sedative antihistamine plus expectorant.[1][2] It is a combination of oxomemazine and guaifenesin.
It is sold under a variety of brand names including Toplexil by Aventis. It is sold over the counter in France, Egypt, Algeria, South Korea and the UAE. The oxomemazine ingredient (antihistamine) is not approved by the U.S. Food and Drug Administration (FDA), either for over the counter or prescription use. French travelers use it as a sleeping aid for long flights.[citation needed]
References
- ↑ Oxomemazine, drugs.com
- ↑ Toplexil, drugs.com
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Drugs that are a combination of chemicals
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Articles with unsourced statements from December 2015
- Combination drugs
- H1 receptor antagonists
- Sanofi
- Sedatives
- Pharmacology stubs